Literature DB >> 3033338

Frequency of 'chronic active Epstein-Barr virus infection' in a general medical practice.

D Buchwald, J L Sullivan, A L Komaroff.   

Abstract

Twenty-one percent of 500 unselected patients, aged 17 to 50 years, seeking primary care for any reason were found to be suffering from a chronic fatigue syndrome consistent with "chronic active Epstein-Barr virus (EBV) infection," They had been experiencing "severe" fatigue, usually cyclic, for a median of 16 months (range, six to 458 months), associated with sore throat, myalgias, or headaches; 45% of the patients were periodically bedridden; and 25% to 73% reported recurrent cervical adenopathy, paresthesias, arthralgias, and difficulty in concentrating or sleeping. The patients had no recognized chronic "physical" illness and were not receiving psychiatric care. While antibody titers to several EBV-specific antigens were higher in patients than in age- and sex-matched controls subjects, the differences generally were not statistically significant. A chronic fatigue syndrome consistent with the chronic active EBV infection syndrome was prevalent in our primary care practice. However, our data offer no evidence that EBV is causally related to the syndrome. Indeed, we feel that among unselected patients seen in a general medical practice currently available EBV serologic test results must be interpreted with great caution.

Entities:  

Mesh:

Year:  1987        PMID: 3033338

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  29 in total

1.  Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Authors:  Rianne Luderer; Marieke Kok; Hubert G M Niesters; Rob Schuurman; Okke de Weerdt; Steven F T Thijsen
Journal:  Mol Diagn       Date:  2005

Review 2.  The epidemiology of fatigue: more questions than answers.

Authors:  G Lewis; S Wessely
Journal:  J Epidemiol Community Health       Date:  1992-04       Impact factor: 3.710

3.  The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study.

Authors:  S Wessely; T Chalder; S Hirsch; P Wallace; D Wright
Journal:  Am J Public Health       Date:  1997-09       Impact factor: 9.308

4.  Comment on unusual manifestations of Epstein-Barr virus (EBV) encephalomyelitis (Infection 18, 1990, 33-35)

Authors:  A Lopez-Navidad; P Domingo
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

5.  Immunologic abnormalities in chronic fatigue syndrome.

Authors:  N G Klimas; F R Salvato; R Morgan; M A Fletcher
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 6.  [Definition of "chronic fatigue syndrome" (CFS)].

Authors:  U Heyll; P Wachauf; V Senger; M Diewitz
Journal:  Med Klin (Munich)       Date:  1997-04-15

Review 7.  Uncommon illness from common infections.

Authors:  C L Christian
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

Review 8.  Chronic fatigue syndrome. A fresh look at an old problem.

Authors:  J McSherry
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

Review 9.  Treatment of the chronic fatigue syndrome. A review and practical guide.

Authors:  E Blondel-Hill; S D Shafran
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Prevalence of chronic fatigue and chronic fatigue syndrome in Korea: community-based primary care study.

Authors:  Cheol Hwan Kim; Ho Cheol Shin; Chang Won Won
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.